1. The American Cancer Society, https://cancerstatisticscenter.cancer.org/. Accessed: 2018-07-11.
2. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin’s lymphoma to apoptosis;Alas;Clin. Cancer Res.,2001
3. A survey of monte carlo tree search methods;Browne;IEEE Trans. Comput. Intell. AI Games,2012
4. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases;Chow;Haematologica,2002
5. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N. Engl. J. Med.,2002